Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.570
+0.050 (1.42%)
Feb 6, 2026, 2:19 PM EST - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.28 billion as of February 6, 2026. Its market cap has decreased by -16.21% in one year.
Market Cap
1.28B
Enterprise Value
1.57B
1-Year Change
-16.21%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.28B, an increase of 248.18%. That is a compound annual growth rate of 8.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.28B | 12.19% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynavax Technologies | 1.76B |
| Harrow | 1.75B |
| ANI Pharmaceuticals | 1.70B |
| Phibro Animal Health | 1.66B |
| Alvotech | 1.59B |
| BioCryst Pharmaceuticals | 1.59B |
| Amylyx Pharmaceuticals | 1.52B |
| Collegium Pharmaceutical | 1.52B |